Related Experiment Video

Updated: May 8, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Expression of ECRG4 is associated with lower proliferative potential of esophageal cancer cells

Junichi Matsuzaki1, Toshihiko Torigoe, Yoshihiko Hirohashi

  • 1Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan.

Pathology International
|August 21, 2013
PubMed

Insights

Epidermalွာ-associated gene 4 (ECRG4) suppresses cell growth and Fas-induced apoptosis. Reduced ECRG4 expression correlates with increased proliferation in esophageal squamous cell carcinoma, identifying it as a potential tumor suppressor.

Area of Science:

  • Molecular biology
  • Cancer research
  • Immunology

Background:

  • Epidermalွာ-associated gene 4 (ECRG4) is expressed in normal human tissues.
  • ECRG4 expression is often reduced in tumor cells.
  • The function of ECRG4 in human tissues and its role in cancer are not fully understood.

Purpose of the Study:

  • To investigate the role of ECRG4 in cell proliferation and apoptosis.
  • To examine the expression of ECRG4 in esophageal squamous cell carcinoma (ESCC).
  • To determine the correlation between ECRG4 expression and proliferation markers in ESCC.

Main Methods:

  • Studied ECRG4's effect on Fas-induced apoptosis in Jurkat cells.
  • Analyzed ECRG4 mRNA expression in normal and tumor tissues.
  • Developed an anti-ECRG4 monoclonal antibody for immunohistochemical analysis.
  • Correlated ECRG4 expression with Ki-67 labeling index in ESCC tissues.

Main Results:

  • ECRG4 suppressed Fas-induced apoptosis in Jurkat cells.
  • ECRG4 mRNA was widely detected in normal tissues but down-regulated in tumor cells.
  • ECRG4 expression suppressed cell growth.
  • Immunohistochemical analysis showed ECRG4-positive cells were in Ki-67 negative regions in ESCC.
  • A significant inverse correlation was found between ECRG4 expression and Ki-67 labeling index in ESCC.

Conclusions:

  • ECRG4 plays a role in suppressing cell proliferation and apoptosis.
  • ECRG4 is downregulated in ESCC, suggesting a tumor suppressor function.
  • Endogenous ECRG4 expression is inversely associated with cell proliferation in ESCC, supporting its role as a candidate tumor suppressor gene.
Keywords:
Ki-67 labeling indexesophageal cancer-related gene 4esophageal squamous cell carcinomatumor suppressor

More Related Videos

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation10:15

Conditional Reprogramming of Pediatric Human Esophageal Epithelial Cells for Use in Tissue Engineering and Disease Investigation

Published on: March 22, 2017

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...